With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...

Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDsOxford, UK ...

The LATAM laboratory equipment and disposables market experienced significant growth in recent years, with a valuation of $1,759 million in 2019. Projections indicate a promising trajectory, with ...